Evonik has agreed to sell its U.S. and Canadian cyanide activities to Oaktree Capital Management for an undisclosed amount. Publicly-traded Evonik recently received a €1.6 billion investment from CVC, while Oaktree recently agreed to buy Nevada Chemicals. www.oaktreecapital.com
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.